Retrograde modulation of presynaptic release probability through signaling mediated by PSD-95-neuroligin
During the review, the committee will likely consider: The extensive body of published research on GHK-Cu (decades of studies) Safety data for both injectable and topical routes The clinical rationale for copper peptide therapy in anti-aging and wound healing Quality control considerations for compounding GHK-Cu formulations Public comments from patients, dermatologists, anti-aging practitioners, and pharmacies Given GHK-Cu's long history of use and substantial research base, many in the peptide therapy community are cautiously optimistic about a positive PCAC recommendation particularly for the topical route
Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies
B12 shots are a standalone service
The direction of modulation is notable: many genes associated with DNA repair, antioxidant response, and tissue remodeling are upregulated, while genes linked to inflammation and tumor progression are downregulated
This announcement does not change the research-only scope of this material and does not introduce any non-research claims or positioning
